Correlation between patient-determined inflammatory bowel disease severity and the inflammatory bowel disease severity index
New Zealand Medical Journal · 13.03.2026 · 139 (1631) · 76-92
DOI: 10.26635/6965.7229 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift New Zealand Medical Journal, online erschienen am 13.03.2026. Verfasst von Andrew Mark McCombie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Health New Zealand - Te Whatu Ora, Christchurch Hospital, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Severity of Illness Index, Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative.
Abstract (Originalsprache)
aim: The inflammatory bowel disease severity index (IBD-DSI) aims to describe inflammatory bowel disease (IBD) severity over the duration of disease. We aimed to correlate the IBD-DSI with a patient-completed disease severity score (PCDSS). We also aimed to investigate whether individual factors such as psychological measures or clinical characteristics moderate this correlation. methods: This multicentre trial involved gastroenterologists completing the IBD-DSI and Harvey-Bradshaw Index or Simple Clinical Colitis Activity Index for each participant while patients completed a self-reported IBD severity score and psychological questionnaires. The excess severity score (ESS) was calculated by subtracting the IBD-DSI from the PCDSS. results: One hundred and sixty-four patients with IBD participated (98.2% response rate; average age 41.2 years; 105 [62.9%] female; 100 [59.9%] Crohn’s disease) and 164 IBD-DSI were completed. The IBD-DSI and PCDSS were positively correlated (r=0.44, r2=0.19, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General Surgery, Health New Zealand - Te Whatu Ora, Christchurch Hospital, Christchurch, New Zealand.
- Center for Digestive Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States of America.
- Northwestern Medicine, Chicago, Illinois, United States of America.
- Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.
- Department of Psychiatry & Center for Digestive Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States of America.
- University of Canterbury, Christchurch, New Zealand.
Zitieren
APA
McCombie, A. M., Siegel, C. A., Hanauer, S. B., McAuliffe, T., Salwen-Deremer, J., Hughes, H., & Gearry, R. (2026). Correlation between patient-determined inflammatory bowel disease severity and the inflammatory bowel disease severity index. New Zealand Medical Journal, 139(1631), 76-92. https://doi.org/10.26635/6965.7229
Vancouver
McCombie AM, Siegel CA, Hanauer SB, McAuliffe T, Salwen-Deremer J, Hughes H, et al. Correlation between patient-determined inflammatory bowel disease severity and the inflammatory bowel disease severity index. New Zealand Medical Journal. 2026;139(1631):76-92. doi:10.26635/6965.7229
BibTeX
@article{McCombie2026,
author = {McCombie, Andrew Mark and Siegel, Corey A and Hanauer, Stephen B and McAuliffe, Timothy and Salwen-Deremer, Jessica and Hughes, Hannah and Gearry, Richard},
title = {Correlation between patient-determined inflammatory bowel disease severity and the inflammatory bowel disease severity index},
journal = {New Zealand Medical Journal},
year = {2026},
volume = {139},
number = {1631},
pages = {76--92},
doi = {10.26635/6965.7229}
}
EUVIMED